Atlas Trials

Study to Identify Biomarkers of Clinical Response to Aflibercept in Patients With Metastatic Colorectal Cancer

Clinical trial NCT02045030 · TERMINATED

Trial details

NCT number
NCT02045030
Sponsor
CR-CSSS Champlain-Charles-Le Moyne
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Metastatic Colorectal Cancer
Start date
2014-01-01
Primary completion
2016-11-01
Enrollment
14

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.